Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.51 Million CHF | 188.45% |
| 2022 | 1.91 Million CHF | -10.86% |
| 2021 | 2.14 Million CHF | -8.29% |
| 2020 | 2.34 Million CHF | -2.01% |
| 2019 | 2.38 Million CHF | 0.0% |
| 2018 | - CHF | 0.0% |
| 2017 | - CHF | 0.0% |
| 2016 | - CHF | -100.0% |
| 2015 | 3.69 Million CHF | -90.17% |
| 2014 | 37.59 Million CHF | 49.36% |
| 2013 | 25.16 Million CHF | 80.83% |
| 2012 | 13.91 Million CHF | -61.03% |
| 2011 | 35.71 Million CHF | -8.51% |
| 2010 | 39.03 Million CHF | -24.73% |
| 2009 | 51.86 Million CHF | -14.82% |
| 2008 | 60.88 Million CHF | 4.26% |
| 2007 | 58.4 Million CHF | 4686.97% |
| 2006 | 1.22 Million CHF | 0.0% |
| 2005 | - CHF | 0.0% |
| 2004 | - CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.56 Million CHF | 0.0% |
| 2023 Q1 | 2.28 Million CHF | 19.65% |
| 2023 Q2 | 2.86 Million CHF | 25.25% |
| 2023 Q4 | 5.51 Million CHF | 252.59% |
| 2023 FY | 5.51 Million CHF | 188.45% |
| 2023 Q3 | 1.56 Million CHF | -45.41% |
| 2022 Q3 | 1.49 Million CHF | -22.84% |
| 2022 Q2 | 1.94 Million CHF | 18.87% |
| 2022 Q1 | 1.63 Million CHF | -23.95% |
| 2022 FY | 1.91 Million CHF | -10.86% |
| 2022 Q4 | 1.91 Million CHF | 27.79% |
| 2021 Q2 | 2.4 Million CHF | 14.8% |
| 2021 FY | 2.14 Million CHF | -8.29% |
| 2021 Q4 | 2.14 Million CHF | 17.33% |
| 2021 Q1 | 2.09 Million CHF | -10.51% |
| 2021 Q3 | 1.82 Million CHF | -23.92% |
| 2020 Q3 | 2.06 Million CHF | -19.11% |
| 2020 Q4 | 2.34 Million CHF | 13.48% |
| 2020 FY | 2.34 Million CHF | -2.01% |
| 2020 Q2 | 2.54 Million CHF | 11.95% |
| 2020 Q1 | 2.27 Million CHF | -4.65% |
| 2019 Q1 | 2.72 Million CHF | 0.0% |
| 2019 Q3 | 2.14 Million CHF | -27.95% |
| 2019 Q2 | 2.97 Million CHF | 9.1% |
| 2019 FY | 2.38 Million CHF | 0.0% |
| 2019 Q4 | 2.38 Million CHF | 11.48% |
| 2018 Q2 | - CHF | 0.0% |
| 2018 Q3 | - CHF | 0.0% |
| 2018 Q1 | - CHF | 0.0% |
| 2018 FY | - CHF | 0.0% |
| 2018 Q4 | - CHF | 0.0% |
| 2017 Q3 | - CHF | 0.0% |
| 2017 FY | - CHF | 0.0% |
| 2017 Q1 | - CHF | 0.0% |
| 2017 Q4 | - CHF | 0.0% |
| 2017 Q2 | - CHF | 0.0% |
| 2016 Q3 | - CHF | 0.0% |
| 2016 FY | - CHF | -100.0% |
| 2016 Q2 | - CHF | 0.0% |
| 2016 Q4 | - CHF | 0.0% |
| 2016 Q1 | - CHF | -100.0% |
| 2015 Q3 | 3.69 Million CHF | 0.0% |
| 2015 FY | 3.69 Million CHF | -90.17% |
| 2015 Q2 | - CHF | 0.0% |
| 2015 Q4 | 3.69 Million CHF | 0.0% |
| 2014 Q4 | 37.59 Million CHF | 0.0% |
| 2014 FY | 37.59 Million CHF | 49.36% |
| 2014 Q2 | 31.32 Million CHF | 0.0% |
| 2013 Q2 | 15.98 Million CHF | 10.35% |
| 2013 Q3 | 17.49 Million CHF | 9.49% |
| 2013 Q1 | 14.48 Million CHF | 4.05% |
| 2013 FY | 25.16 Million CHF | 80.83% |
| 2013 Q4 | 25.16 Million CHF | 43.85% |
| 2012 Q4 | 13.91 Million CHF | 10.32% |
| 2012 Q1 | 8.59 Million CHF | -75.93% |
| 2012 Q2 | 11.69 Million CHF | 36.09% |
| 2012 Q3 | 12.61 Million CHF | 7.85% |
| 2012 FY | 13.91 Million CHF | -61.03% |
| 2011 Q2 | 39.95 Million CHF | 1.15% |
| 2011 Q3 | 38.09 Million CHF | -4.65% |
| 2011 Q4 | 35.71 Million CHF | -6.24% |
| 2011 FY | 35.71 Million CHF | -8.51% |
| 2011 Q1 | 39.49 Million CHF | 1.17% |
| 2010 Q1 | 44.82 Million CHF | -13.56% |
| 2010 FY | 39.03 Million CHF | -24.73% |
| 2010 Q4 | 39.03 Million CHF | 1.1% |
| 2010 Q3 | 38.61 Million CHF | 1.11% |
| 2010 Q2 | 38.19 Million CHF | -14.81% |
| 2009 Q4 | 51.86 Million CHF | 0.0% |
| 2009 FY | 51.86 Million CHF | -14.82% |
| 2008 FY | 60.88 Million CHF | 4.26% |
| 2007 FY | 58.4 Million CHF | 4686.97% |
| 2006 FY | 1.22 Million CHF | 0.0% |
| 2005 FY | - CHF | 0.0% |
| 2004 FY | - CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|